1. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression
   Martin Asslaber et al, 2016, Journal of Neuropathology & Experimental Neurology CrossRef
2. Wnt/β‐catenin signaling cascade: A promising target for glioma therapy
   Lu He et al, 2019, Journal of Cellular Physiology CrossRef
3. Review targeted drug delivery systems for norcantharidin in cancer therapy
   Bing-Tao Zhai et al, 2022, Journal of Nanobiotechnology CrossRef
4. Protein Phosphatase 2A Inhibiting β-Catenin Phosphorylation Contributes Critically to the Anti-renal Interstitial Fibrotic Effect of Norcantharidin
   Zheng Xiao et al, 2020, Inflammation CrossRef
5. Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
   Lei Wang et al, 2022, Frontiers in Pharmacology CrossRef
6. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
   Mu-Su Pan et al, 2020, Chinese Medicine CrossRef
7. Cantharidin inhibits melanoma cell proliferation via the miR‑21‑mediated PTEN pathway
   Zhen Mu et al, 2018, Molecular Medicine Reports CrossRef
8. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years
   Jianbo Zhou et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. RNA‐Seq analysis of potential lncRNAs and genes for the anti‐renal fibrotic effect of norcantharidin
   Hengting Xiao et al, 2019, Journal of Cellular Biochemistry CrossRef
10. Structure, function and disease relevance of Wnt inhibitory factor 1, a secreted protein controlling the Wnt and hedgehog pathways
    Krisztina Kerekes et al, 2019, Growth Factors CrossRef